Vistagen Therapeutics Inc (VTGN)
4.45
-0.10
(-2.20%)
USD |
NASDAQ |
May 17, 16:00
4.45
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics Cash from Financing (Quarterly): 93.52M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 93.52M |
| September 30, 2023 | 34.18M |
| June 30, 2023 | 0.8756M |
| March 31, 2023 | -0.3987M |
| December 31, 2022 | -0.3041M |
| September 30, 2022 | -0.334M |
| June 30, 2022 | -0.0055M |
| March 31, 2022 | 0.0237M |
| December 31, 2021 | 2.118M |
| September 30, 2021 | 7.350M |
| June 30, 2021 | 0.9914M |
| March 31, 2021 | 4.085M |
| December 31, 2020 | 94.07M |
| September 30, 2020 | 12.95M |
| June 30, 2020 | 2.998M |
| March 31, 2020 | 2.871M |
| December 31, 2019 | 1.270M |
| September 30, 2019 | -0.0879M |
| June 30, 2019 | -0.0418M |
| March 31, 2019 | 10.38M |
| December 31, 2018 | 2.361M |
| September 30, 2018 | 4.663M |
| June 30, 2018 | 0.0236M |
| March 31, 2018 | -0.0499M |
| December 31, 2017 | 13.71M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.014M |
| June 30, 2017 | 0.841M |
| March 31, 2017 | 0.0723M |
| December 31, 2016 | 0.2123M |
| September 30, 2016 | -0.035M |
| June 30, 2016 | 9.744M |
| March 31, 2016 | 0.6014M |
| December 31, 2015 | 1.638M |
| September 30, 2015 | 2.079M |
| June 30, 2015 | 0.8743M |
| March 31, 2015 | 0.9513M |
| December 31, 2014 | 0.3542M |
| September 30, 2014 | 0.1209M |
| June 30, 2014 | 1.412M |
| March 31, 2014 | 0.4464M |
| December 31, 2013 | 0.3326M |
| September 30, 2013 | 0.5254M |
| June 30, 2013 | 0.1931M |
| March 31, 2013 | 1.588M |
| December 31, 2012 | 1.104M |
| September 30, 2012 | 1.216M |
| June 30, 2012 | 0.2469M |
| March 31, 2012 | 0.6522M |
| December 31, 2011 | 1.136M |
| September 30, 2011 | -0.1375M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.3987M
Minimum
Mar 2023
94.07M
Maximum
Dec 2020
13.48M
Average
1.270M
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
| Ardelyx Inc | 52.97M |
| Axsome Therapeutics Inc | -1.187M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 4.005M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.535M |
| Cash from Investing (Quarterly) | -0.0323M |
| Free Cash Flow | -26.12M |
| Free Cash Flow Per Share (Quarterly) | -0.1554 |
| Free Cash Flow to Equity (Quarterly) | -4.568M |
| Free Cash Flow to Firm (Quarterly) | -4.568M |
| Free Cash Flow Yield | -43.60% |